Immunic, Inc. (IMUX) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped IMUX stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Immunic, Inc. (IMUX) demonstrates promise as an innovative biopharmaceutical company with impactful clinical progress, esteemed analyst enthusiasm, and a valuable drug pipeline. While competitive and cost-related risks exist, the potential market and revenue from their primary candidate IMU-838 present substantial medium-to-long-term value. Given its strong fundamentals and anticipated regulatory advancements, Immunic's valuation stands to grow considerably over time, rewarding long-term investors, albeit with acknowledged project and market risks. The saved 1-year distribution is P10 $1, P50 $2.7, and P90 $5.
Last analyzed · Model: gpt-4o
Immunic, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $1 | Pessimistic plausible scenario |
| P50 | $2.7 | Median scenario |
| P90 | $5 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Immunic, Inc. has several bullish indicators within the one-year timeframe, such as the strong analyst consensus rating of STRONG BUY, clinical trial successes, and the recent upward price movement. However, risks exist from competitive pressure and concerns over R&D costs.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this IMUX analysis generated?
March 11, 2026.
Is this a guaranteed IMUX prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full IMUX stock analysis · IMUX sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.